Latest Breaking News On - Katholisches klinikum bochum - Page 1 : comparemela.com

COPAXONE® label updated to help breastfeeding mothers with relapsing MS

Teva Pharmaceuticals Europe BV has confirmed that the SmPC for COPAXONE® (Glatiramer Acetate (GA) injection) 20mg/mL and 40mg/mL, indicated for the treatment of relapsing forms of multiple sclerosis (RMS) in Europe, has been updated.

United statesMariak houtchensAmyl phillipsNataliec edwardsKerstin hellwigKatholisches klinikum bochumDanilo lemboGary schneiderNational german multiple sclerosisDepartment of neurologyTeva pharmaceuticals europeEuropean academy of neurologyTeva pharmaceutical industriesTeva pharmaceuticalsGlatiramer acetatePregnancy registry

Teva Pharmaceutical Industries Limited: COPAXONE Label Now Indicates Its Use in Breastfeeding Mothers with Relapsing Multiple Sclerosis

Change to COPAXONE(Glatiramer Acetate (GA)) Summary of Product Characteristics (SmPC) in breastfeeding is relevant for the Multiple Sclerosis ("MS") community and provides information for neurologists

United statesNataliec edwardsKerstin hellwigKatholisches klinikum bochumDanilo lemboMedizinprodukte bfarGary schneiderFiona cohenMariak houtchensAmyl phillipsNational german multiple sclerosisDepartment of neurologyTeva pharmaceuticals europeEuropean academy of neurologyTeva pharmaceuticalsTeva pharmaceutical industries ltd

New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live with Relapsing Multiple Sclerosis

New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live with Relapsing Multiple Sclerosis
dutchnews.nl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dutchnews.nl Daily Mail and Mail on Sunday newspapers.

United statesNoord hollandThomas haleTeva europeKerstin hellwigDanilo lemboSaneea almasKatholisches klinikum bochumFiona cohenTeresa bakerJesse vanceDepartment of neurologySclerosis international volumeTeva pharmaceuticals europeRuhr university bochumTeva pharmaceuticals

New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live with Relapsing Multiple Sclerosis

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesTeva europeKerstin hellwigDanilo lemboKatholisches klinikum bochumFiona cohenDepartment of neurologyTeva pharmaceuticals europeTeva pharmaceutical industriesRuhr university bochumTeva pharmaceuticalsTeva pharmaceutical industries ltdJosef hospitalPrincipal study investigatorGerman multiple sclerosisPregnancy registry